AI/ML Trends in Clinical Trials (2010-2023)
📈 Rapid increase in AI/ML studies post-2017, 62.8% from 2021-2023
⚕️ 56.2% randomized, 58.9% prospective designs in trials
🏥 Major sponsors: hospitals/clinics (44.2%), academia (28%)
🌍 Dominantly located in high-income countries (75.3%)
📉 Low result reporting: only 5.6% available at study completion
#AI #ML #ClinicalTrials #HIC #RCT #Healthcare #Pub2Post
DOI: https://dev.https://tnyp.me/e6M2kG8b/m














